Organ Preservation Solutions Market Anticipated to Hit US$ 574.7 Million at a CAGR of 7.2% by 2035 | Fact.MR Report

The world organ preservation solutions market is anticipated to witness high growth over the next ten years due to rising organ transplantation procedures, growing organ failure cases, and advances in organ preservation techniques. Valued at USD 286.8 million in 2025, the value is anticipated to increase to around USD 574.7 million by 2035, at a steady CAGR of 7.2% over the forecast period.

Organ preservation solutions are absolutely critical to the maintenance of organ viability and function from procurement through to transplantation. Such approaches remain pivotal in achieving the maximum in transplant success via minimization of ischemic damage and increase of the window for safe preservation, most importantly organs such as kidney, liver, heart, lungs, and pancreas.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7752

Country-wise Analysis

The U.S. market for organ preservation solutions is anticipated to witness a CAGR of 6.4% between 2025 and 2035. The growth driver is largely driven by the demand for organ transplantation, aided by strong infrastructure at advanced healthcare centers.

The UK organ preservation solution market is anticipated to register a CAGR of 5.7% throughout the forecast period. Rising awareness among the general population and an increase in organ failure cases are driving higher transplantation programs in NHS-associated hospitals. Anxiety for maximizing donor organ viability is driving the adoption of both machine perfusion and static cold storage systems.

The French market for organ preservation solutions is anticipated to have a CAGR of 5.2% from 2025 to 2035. Higher rates of organ donation and policy reforms at the national level are propelling demand for efficient preservation systems. Well-established organ transplant facilities in the country facilitate continuous usage of preservation fluids for longer storage periods.

Germany is expected to register a CAGR of 5.5% in the 2025 to 2035 timeline for the market of organ preservation solutions. Measures to encourage donor registrations by governments are complemented by increasing end-stage organ disease and growing expansion. The healthcare innovation focus in the country is boosting the adoption of new preservation solutions in academia as well as clinical institutions.

Segment-wise Analysis

By Technique

Owing to technological improvements in transplantation methods and the growing world demand for healthy donor organs, the stationary cold storage segment is expected to have a share of 45.1% in 2025. The SCS is taken as the standard technique of organ preservation owing to its simplicity, affordability, and widespread usage.

By Organ Type

Organ-wise, the market for organ preservation solutions for the year 2025 is divided with the largest contribution of approximately 34.5% from kidneys. The maximum contribution is due to kidney transplants having a large worldwide volume being the most common transplant done worldwide due to end-stage renal disease (ESRD).

Competitive Outlook

The market for organ preservation solutions is competitively positioned, and top companies are focused on ensuring maximum preservation efficiency, organ viability, and hence, transplant success rates. Upon formulating preservation solutions in-house for different kinds of organs, primarily the kidney, liver, and heart, the companies add cryopreservation and machine perfusion technologies to them. Competitor differentiation further occurs due to strategic collaborations with transplant facilities as well as regulations improvement.

Innovations in preservation technologies are prime determining characteristics, with major corporations investing in hypothermic as well as normothermic perfusion technologies to enhance organ function prior to transplant. The need is also rising for cell-based preservation technologies as well as rationalized perfusate compositions. Corporations, besides being occupied with regulatory approval and clinical demonstration of their technologies, are making the industry's reputation more solid to advocate take-up.

Browse Full Report: https://www.factmr.com/report/organ-preservation-solutions-market

Key Players

XVIVO Perfusion AB
BioLife Solutions, Inc.
Essential Pharmaceuticals, LLC
Lifeline Scientific, Inc.
Bridge to Life Ltd.
Preservation Solutions, Inc.
OrganOx Limited
Teva Pharmaceutical Industries Ltd.
Paragonix Technologies Inc.
ToleroTech, Inc.
Claris Injectables Limited
Accord Healthcare

Segmentation

By Technique :
Cold storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ Type :
Kidneys
Liver
Lungs
Heart
Others
By End User :
Organ Transplant Centers
Hospitals
Specialty Clinics
By Region :
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

Check out More Related Studies Published by Fact.MR:

Fiducial Markers Market
https://www.factmr.com/report/1026/fiducial-marker-market
Inflation Devices Market
https://www.factmr.com/report/inflation-devices-market
Disabled and Elderly Assistive Technology Market
https://www.factmr.com/report/disabled-and-elderly-assistive-technology-market
Diagnostic Imaging Centers Market
https://www.factmr.com/report/diagnostic-imaging-centers-market.

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.